Advaxis Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Advaxis Inc.

Advaxis Inc. | Ownership

Companies that own Advaxis Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Adage Capital Management LP

3,000,000

5.68%

-500,000

0.01%

06/30/2018

The Vanguard Group, Inc.

1,763,798

3.34%

-273,533

06/30/2018

BlackRock Fund Advisors

1,388,036

2.63%

-1,384,921

06/30/2018

PZU Asset Management SA

830,000

1.57%

61,760

0.13%

06/30/2017

DAFNA Capital Management LLC

697,000

1.32%

0.39%

06/30/2018

D. E. Shaw & Co. LP

637,383

1.21%

-1,123

06/30/2018

Goldman Sachs & Co. LLC (Private Banking)

457,403

0.87%

363,921

06/30/2018

Renaissance Technologies LLC

436,494

0.83%

-555,900

06/30/2018

Millennium Management LLC

323,615

0.61%

323,615

06/30/2018

Element Capital Management LLC

210,749

0.4%

210,749

0.01%

06/30/2018

About Advaxis

View Profile

Address	305 College Road East Princeton New Jersey 08540 United States
Employees	-
Website	http://www.advaxis.com
Updated	07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.